Exacerbations and Real-World Outcomes Among Patients With Chronic Obstructive Pulmonary Disease Following Severe Exacerbation

Clinical trial NCT07414134 · COMPLETED

Trial details

NCT number: NCT07414134
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2025-10-31
Primary completion: 2025-11-28
Enrollment: 3598

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.